Navigation Links
KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results
Date:8/11/2008

in the meaning of the United States Private Securities Litigation Reform Act of 1995 ("PSLRA") and which may be based on or include assumptions concerning KV's operations, future results and prospects. Such statements may be identified by the use of words like "plans", "expect", "aim", "believe", "projects", "anticipates", "commit", "intend", "estimate", "will", "should", "could" and other expressions that indicate future events and trends.

All statements that address expectations or projections about the future, including without limitation, statements about the Company's strategy for growth, product development, product launches, regulatory approvals, market position, market share increases, acquisitions, revenues, expenditures and other financial results, and expectations and beliefs pertaining to the announced Audit Committee inquiry or any allegations of misconduct that are the subject of such inquiry, are forward-looking statements.

All forward-looking statements are based on current expectations and are subject to risk and uncertainties. In connection with the "safe harbor" provisions, KV provides the following cautionary statements identifying important economic, political and technology factors, which among others, could cause actual results or events to differ materially from those set forth or implied by the forward-looking statements and related assumptions.

Such factors include (but are not limited to) the following: (1) changes in the current and future business environment, including interest rates and capital and consumer spending; (2) the difficulty of predicting FDA approvals, including timing, and that any period of exclusivity may not be realized; (3) acceptance and demand for new pharmaceutical products; (4) the impact of competitive products and pricing, including as a result of so-called authorized-generic drugs; (5) new product development and launch, including the possibility that any product launch may be delayed or tha
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2015)... (PRWEB) April 18, 2015 "I ... decided to create a healthful juice that contained ... from Rosedale, Md. "It increases my energy, improves ... body." , He developed Tapp's Juice to contain ... helps to prevent physical and mental fatigue. It ...
(Date:4/18/2015)... 18, 2015 Review of Ophthalmology magazine ... ‘Strategies for Success’ program for cataract surgeons attending the ... San Diego, where eye surgeon Jeffrey L. Martin, MD ... event. Dr. Martin is the Managing Partner of North ... chose Dr. Martin to lead this year’s discussion on ...
(Date:4/18/2015)... Insuranceautoquote.info has released a new blog ... quotes . , Clients can review important auto ... online environment provides important advantages for clients who need ... who do not have coverage for their vehicles can ... day or hour. Many agencies offer important discounts and ...
(Date:4/18/2015)... Lowcostcarinsuranceprice.com has released a new blog post ... auto insurance prices . , Drivers who live ... may have to pay more for auto insurance plans ... can also offer protection against vehicle theft. , ... on a single website: http://lowcostcarinsuranceprice.com/ . Drivers ...
(Date:4/18/2015)... Lower-auto-insurance.com has released a new blog ... insurance quotes . , Drivers can find accurate ... A professional insurance brokerage website can help drivers compare ... simple, convenient way. The whole process is designed to ... Comparing online car insurance quotes is advantageous because it ...
Breaking Medicine News(10 mins):Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2Health News:Clients Can Review Car Insurance Quotes Online To Find Low Cost Offers! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:Auto Insurance Quotes Can Provide Accurate Results! 2
... less likely than non-Hispanic whites to call 9-1-1 and be ... in medical treatment delays according to a new study ... ., For the study, researchers used data from the Brain ... hospital arrival time and use of ambulance or emergency medical ...
... with a coalition of 20 international sites in five ... who have had optical coherence tomography (OCT) of the ... researchers hope will give doctors a better means to ... and sudden cardiac death. When a vulnerable ...
... say , THURSDAY, March 25 (HealthDay News) -- New research ... cancer may actually improve their survival odds, a notion contrary ... finding is significant, given that the death rate from breast ... pregnancy until later in life, the study authors said. , ...
... compared to about three-quarters of whites, Hispanics, CDC says ... the health-boosting powers of breast-feeding aren,t reaching black American ... a new study from the U.S. Centers for Disease ... that while more than 80 percent of Hispanic mothers ...
... how tumors escape the body,s natural immune surveillance has recently ... Switzerland. The study shows how tumors can create a tolerant ... key features of lymph nodes. The discovery, published in ... 25, 2010, underscores the role of the lymphatic system in ...
... ... to Raise Awareness About Malaria Prevention Aboard an Eco-Friendly Bus , ... Atlanta, GA (Vocus) March 25, 2010 -- The United ... in Africa — announced today the launch of its Nothing But Nets Buzz Tour. The ...
Cached Medicine News:Health News:Mexican Americans less likely than whites to call 9-1-1 for stroke 2Health News:Mexican Americans less likely than whites to call 9-1-1 for stroke 3Health News:Mass. General Hospital to create registry for coronary optical coherence tomography 2Health News:Pregnancy May Protect Breast Cancer Survivors 2Health News:Pregnancy May Protect Breast Cancer Survivors 3Health News:Black Women Least Likely to Breast-Feed in U.S. 2Health News:Black Women Least Likely to Breast-Feed in U.S. 3Health News:Tumors hide out from the immune system by mimicking lymph nodes 2Health News:Grassroots Campaign Drives toward Ending Malaria Deaths by 2015 2Health News:Grassroots Campaign Drives toward Ending Malaria Deaths by 2015 3
(Date:4/17/2015)... , April 17, 2015 /CNW/ - The ... Inc. (GSK) is voluntarily recalling one lot (lot 710535) of ... two glass pieces had been found in one bottle of ... affected at this time. Clavulin-400 is an oral ... older to treat various bacterial infections. Clavulin-400 comes as a ...
(Date:4/17/2015)... Contego Medical, the first and only ... for angioplasty balloon and stent delivery catheters, announces ... financing round led by Hatteras Venture Partners, an ... medical devices, biopharmaceuticals, diagnostics and related opportunities in ... Partners, Lookout Capital and Medical Mutual. ...
(Date:4/17/2015)... HILL, N.C. , April 17, 2015  Regulatory ... the newly released bipartisan discussion draft called "21 st ... document is planned to be taken up by Congress ... how pharmaceutical and medical device products are developed and ... For that reason, many companies have begun to consider ...
Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 2Contego Medical Closes $5.6 Million in Series B Funding 2Contego Medical Closes $5.6 Million in Series B Funding 321st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2
... Data from 1,237 Facilities Demonstrates,Public Health ... States,Across Healthcare Facility Units, SAN JOSE, ... The,Association for Professionals in Infection Control ... from a nationwide study of,1,237 U.S. ...
... Is Commonly Seen In,Insulin Therapy , CHICAGO, June ... a new study that further demonstrated the safety ... Patients with Type 2 diabetes were able ... improvements in blood,sugar, comparable to dosing adjusted by ...
Cached Medicine Technology:Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 2Largest National U.S. Healthcare Facility MRSA Study Reveals,Infection Rates Eight Times Greater Than Previous Estimates 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5
Colloidal Gold Sol, 40 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 30 nm 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: